Evidence map›Paper›PMID 40450056›Full record

ArticleScientific reports2025

TropD-detector a CRISPR/LbCas12a-based system for rapid screening of Trypanosoma cruzi in Chagas vectors and reservoirs.

Luis A Ortiz-Rodríguez, Rafael Cabanzo, Jeiczon Jaimes-Dueñez, Stelia C Mendez-Sanchez, Jonny E Duque

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luis A Ortiz-RodríguezCentro de Investigaciones en Enfermedades Tropicales(Cintrop). Escuela de Medicina, Departamento de Ciencias Básicas, Universidad Industrial de Santander, Parque Tecnológico y de Investigaciones Guatiguará Km 2 El Refugio, Piedecuesta, Santander, Colombia.
Rafael CabanzoLaboratorio de Espectroscopía Atómica y Molecular (LEAM), COL0012909, Escuela de Física, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia.
Jeiczon Jaimes-DueñezGrupo de Investigación en Ciencias Animales GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia UCC, Bucaramanga, Colombia.
Stelia C Mendez-SanchezGrupo de Investigación en Bioquímica y Microbiología GIBIM, Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia.
Jonny E DuqueCentro de Investigaciones en Enfermedades Tropicales(Cintrop). Escuela de Medicina, Departamento de Ciencias Básicas, Universidad Industrial de Santander, Parque Tecnológico y de Investigaciones Guatiguará Km 2 El Refugio, Piedecuesta, Santander, Colombia. jonedulu@uis.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease, also known as American Trypanosomiasis, is a zoonosis with global distribution caused by the parasite Trypanosoma cruzi, primarily transmitted through the feces of infected triatomines. The emergence of new cases highlights the importance of early pathogen detection in vectors and reservoirs to generate effective control strategies and establish preventive policies. The objective of this study was to design and validate a detection system of T. cruzi based on specific DNA cleavage, activation of Cas12a and trans-cleavage, targeting the genes Cytochrome B (Cytb), 18 S ribosomal subunit (SR18 s), and histone (H2 A). This system was validated for their uses in both vectors and reservoirs of the parasite. The initial step involved performing a bioinformatic analysis of the target genes, followed by the design of RNA guides specific to each cleavage site, along with primers for amplifying the target region through PCR and RPA. Subsequently, we sequenced the amplified DNA target and validated the detection system using T. cruzi DNA extracted from naturally infected Rhodnius pallescens in the metropolitan area of Bucaramanga, Colombia. After standardizing the method, we tested the CRISPR/Cas system with Silvio X10 laboratory strain of T. cruzi and scaled up to blood samples of naturally infected Didelphis marsupialis. As a result, we observed DNA cleavage using the CRISPR/Cas system with the Cytb guide, achieving a detection sensitivity of 118 parasite equivalents/mL in PCR and 116 parasite equivalents/mL with RPA amplification. Sequencing of the Cytb gene showed no mutations in the cleavage site. However, point mutations and indels were found in SR18S and H2 A, avoiding the formation of the CRISPR/LbCas12 complex. Furthermore, we introduce the design of a fluorescent detection prototype with CRISPR/LbCas12a called "Tropical Diseases Detector" (TropD-Detector). This device operates with an excitation wavelength of 480 nm emitted by an LED and a high-pass light filter with a cutoff wavelength of 500 nm. We detected positive samples using any photographic camera system. The TropD-Detector provides a visual, viable, and sensitive method for detecting T. cruzi in both vectors and reservoirs from endemic areas.

Indexed as

Chagas DiseaseCRISPR-Cas SystemsDisease ReservoirsTrypanosoma cruziAnimalsBacterial ProteinsCRISPR-Associated ProteinsCytochromes bEndodeoxyribonucleasesHistonesRhodniusBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsCytochromes bEndodeoxyribonucleasesHistonesChagasCRISPR/LbCas12aDiagnosticSensorsVectors

Identifiers

PMID40450056
PMCPMC12126480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.